Clinical studies - Dry Eye

Author/s  Title / External Links
GENERAL
T. Shahraki, et al. New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief
M. Vidal-Rohr a, J.P. Craig b, L.N. Davies a, J.S. Wolffsohn The epidemiology of dry eye disease in the UK: The Aston dry eye study
Che Arif, Fatin & Hilmi, Mohd Radzi & Kamal, Khairidzan & Ithnin, Mohd
Evaluation of 18 artificial tears based on viscosity and pH. Malaysian Journal of Ophthalmology
Yun-Jung Yang, Won-Young Lee, Young-jin Kim, Yeon-pyo Hong
A Meta-Analysis of the Efficacy of Hyaluronic Acid Eye Drops for the Treatment of Dry Eye Syndrome
M  Moshirfar, W. B. West Jr. & D. P. Marx 
Face Mask-Associated Ocular Irritation and Dryness
http://www.mims.co.uk 

Ophthalmic Preparations, Preservatives and Potential Sensitisers as Ingredients 

Potential sensitising agents in eye drops and ointments.

The Ocular Surface Journal

Jul-17

Volume 15, Issue 3, p269-650

 

TFOS International Dry Eye WorkShop (DEWS II) 

C Baudouin, et al. 

 Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction

The Ocular Surface Journal

April 2007 

Volume 5, Number 2

International Dry Eye Workshop (DEWS) 2007  

Pasquale Aragona, Vincenzo Papa, Antonio Micali, Marcello Santocono, Giovanni Milazzo  

Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye 

H Mochizuki, M Yamada, S Hato and T Nishida

Fluorophotometric measurement of the precorneal residence time of topically applied hyaluronic acid

Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudoin C Graefes Arch Clin Exp Ophthalmol. 2005 Jun;243(6):531-8. Epub 2004 Dec 17

Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis  

Prabhasawat P, Tesavibul N, Kasetsuwan N. Br. J. Ophthalmol. 2007;91;47-50

Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study   

REMOGEN® OMEGA

 

NEW: Kaercher T, et al. Topical Omega-3 Polyunsaturated Fatty Acids for
the Treatment of Dry Eye – Results from a Pilot
Randomized Controlled Masked-Observer Study

Fevziye Ondes Yilmaz, et al. 

Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking : Short term results

Stefano Barabino, et al.

 The role of systemic and topical fatty acids for dry eye treatment https://doi.org/10.1016/j.preteyeres.2017.05.003

VISMED® 

 

NEW: Calonge et al. Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease

NEW: Emine Esra Karaca, Dilay Özek, Özlem Evren Kemer

Comparison study of two different topical lubricants on tear meniscus and tear osmolarity in dry eye 

Szegedi S, et al. 

 Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome 

Baeyens V, Fiorentini R, Baudouin C, Dorsey F and The French VISMED® Study Group 

Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye (Need to register to access full free pdf file) 

Ralph Pinheiro, Claudia Panfil, Norbert Schrage, Ralf Michael Dutescu

Comparison of the lubricant eyedrops Optive®, Vismed Multi®, and Cationorm® on the corneal healing process in an ex vivo model 

Roger Vogel, R. Stephens Crockett, Neal Oden, Terry W. Laliberte, and Luis Molina, on behalf of the sodium hyaluronate ophthalmic solution study group 

Demonstration of Efficacy in the Treatment of Dry Eye Disease with 0.18% Sodium Hyaluronate Ophthalmic Solution (Vismed, Rejena)  

C.A. Kirby, and The Vismed Study Group. Invest. Ophthalmol. Vis. Sci. 2009; 50 : E-Abstract 4648-D892. Poster presented at the ARVO, Fort-Lauderdale, 3-7 May 2009

Superiority of Vismed® (Sodium Hyaluronate Ophthalmic Solution 0.18%) Compared with its Vehicle in the Treatment of the Signs and Symptoms of Dry Eye Disease

Baeyens V, Fiorentini R, Baudouin C, Dorsey F and The French VISMED® Study Group 

Efficacy and safety of sodium hyaluronate 0.18% (VISMED®) vs sodium chloride 0.9% in patients with bilateral moderate dry eye  

Zeher M, Bereczki Á, Sohajda Z, Márta J, Deák G, Ibnou-Zekri N, Baeyens V, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008 

 

A 1-month study of efficacy and safety of 0.18% sodium hyaluronate (Vismed®) vs. 0.3% carbomer and 0.9% saline in patients with bilateral moderate dry eye syndrome 

Johnson ME, Murphy PJ, Boulton M Graefes Arch Clin Exp Ophthalmol. 2006 Jan;244(1):109-12. Epub 2005 Jun 28.

Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye 

Aleo D, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008  

Considerations on the risk of precipitation of calcium phosphate salts following the use of VISMED® (0.18% sodium hyaluronate) formulation  

Rapisarda A, Battaglia F, Bossy L, poster presented at the 7th International Symposium on Ocular Pharmacology (ISOPT)-Budapest, Hungary, February 28- March 2, 2008 

Efficacy and safety of hypotonic 0.18% sodium hyaluronate solution (VISMED®) in patients with moderate dry eye - A study of the osmolarity of the tear film  

Michael E. Johnson, Paul J. Murphy, Mike Boulton  

Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment   

VISMED® GEL 

 

NEW: Calonge et al. Sodium hyaluronate 0.30% ocular gel versus sodium hyaluronate 0.18% eye drop in the treatment of moderate to severe dry eye disease

NEW: F A Che Arif, K Kamal, M R Hilmi, M H Ithnin

VISMED® GEL (Non-Preserved Sodium Hyaluronate eye drops) for the Treatment of Symptoms of Ocular Dryness and Discomfort in Patients with Sjögren's Syndrome  

Clive Peckar 

 

The Use of Sodium Hyaluronate Gel 0.3% in the Management of Post-Keratoplasty Patients, Chronic Refractory Dry Eye Patients and other Surface Problems 

Clive Peckar 

Article in Eurotimes.

Sodium Hyaluronate Based Products. Management of post-LASIK dry eye and other dry eye problems. 

Clive Peckar, et al

Eurotimes Roundtable 

 Current Trends in the management of dry eye

LASERVIS

 

Dougherty P.J., Wellish K.L., Maloney R.K. (1994)

Excimer Laser Ablation Rate and Corneal Hydration. Am. J of Ophthalm. 118, 169-176 

Arshinoff SA, Khoury E. 

J Cataract Refract Surg 1997; 23:1221-5.

HsS versus a balanced salt solution as a corneal wetting agent during routine cataract extraction and lens implantation  

Alio J.L., Belda J.I., Shalaby A.: 

2001;108:1246-1260 American Academy of Ophthalmology 

Correction of Irregular Astigmatism with Excimer Laser Assisted by Sodium Hyaluronate  

Vinciguerra P, Camesasca FI. 

J Refract Surg 2002; 18(3 Suppl):S371-3. 

Butterfly laser epithelial keratomileusis for myopia  

Lombardo M, Serrao S.(2004): 

Excimer Lasers. Journal of Refractive Surgery Vol 20 September/October 2004 

Smoothing of the ablated porcine anterior corneal surface using Technolas Keratocor 217C and Nidek EC-5000 

Vinciguerra P., Camesasca FI, Torres IM 

Journal of Refractive Surgery Volume 20 September/October (Suppl) 2004

One-year results of custom laser epithalial keratomileusis with the Nidek system  

J Cataract Refract Surg 2005;31:39-47 ASCRS & ESCRS 

Vinciguerra P., Camesasca F.I., Torres Munoz M.I. (2005):  

Transition zone design and smoothing in custom laser-assisted subepithelial keratectomy  

Vinciguerra P, Munoz MI, Camesasca FI, Grizzi F, Roberts C. 

J Cataract Refract Surg. 2005 Jan;31(1):82-7. 

Long-term follow-up of ultrathin corneas after surface retreatment with phototherapeutickeratectomy. 

Lombardo M, De Santo MP, Barberi R, Serrao S. 

J Refract Surg. 2005 Sep-Oct;21(5):469-75 

Roughness of excimer laser ablated corneas with and without smoothing measured with atomic force microscopy   

VISIOL ®

Belda JI, Artola A, Garcia-Manzanares MD, Ferrer C, Haroun HE, Hassanein A, Baeyens V, Munoz G, Aliò JL 

J Cataract Refract Surg 2005; 31:1213-1218 © 2005 ASCRS and ESCRS 

Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: Experimental Model 

Miranda M, Bosch-Morell F, Belda JI, García-Manzanares MD, Barcia J, Alió JL, Romero FJ 

Ophthalmic Res. 2007;39(5):260-4. Epub 2007 Sep 12. 

Protective Effect of Viscoelastics against Retina Lipid Peroxidation 

Peckar C, study results presented at the 24th congress of the Asia-Pacific Academy of Ophthalmology (APAO)-Bali, Indonesia, May 17th, 2009  

New OVDs: Does 2% Sodium Hyaluronate (VISIOL®) have significant advantages over 1% Sodium Hyaluronate to justify its use in Routine Cataract Phacoemulsification? 

 

For other studies not shown on this list please contact TRB Chemedica (UK) Ltd:

TRB Chemedica (UK) Ltd
9 Evolution 
Lymedale Business Park 
Hooters Hall Road 
Newcastle-under-Lyme 
ST5 9QF

Tel: 0845 330 7556
Email: info@trbchemedica.co.uk